Drug Manufacturers - General · Healthcare
Board Member
2022-01-01–present
Board Member
Johnson & Johnson (JNJ)Equibles does not estimate personal net worth.
Get an email with a short summary when Johnson & Johnson publishes a filing, an earnings call transcript or a press release.
Get JNJ alertsJ. Duato is recorded as Board Member at Johnson & Johnson (JNJ) since January 1, 2022. The newest filing on record that lists J. Duato as Board Member at Johnson & Johnson (JNJ) is dated March 11, 2026. The proxy statement of Johnson & Johnson reports total compensation of $32,758,111 for J. Duato in fiscal 2025, including a base salary of $1,600,000. Disclosed compensation is on record for 6 fiscal years. Johnson & Johnson is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Johnson & Johnson includes J. Wolk (CFO), D. E. Pinto (Board Member), Daniel Pinto (Board Member) and 7 others.
2022-01-01–present
Last confirmed March 11, 2026
Drug Manufacturers - General · Healthcare
Board Member
2022-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Johnson & Johnson (JNJ) | Chairman/CEO | $1,600,000 | $32,758,111 |
| 2024 | Johnson & Johnson (JNJ) | Chairman/CEO | $1,600,000 | $24,302,360 |
| 2023 | Johnson & Johnson (JNJ) | Chairman/CEO | $1,584,615 | $28,397,240 |
| 2022 | Johnson & Johnson (JNJ) | Chairman/CEO | $1,490,962 | $13,099,487 |
| 2021 | Johnson & Johnson (JNJ) | Chairman/CEO | $1,030,000 | $13,805,292 |
| 2020 | Johnson & Johnson (JNJ) | Chairman/CEO | $1,021,538 | $15,625,003 |
No call appearances or filed executive changes recorded yet.